GLPG1790: The first Ephrin (EPH) receptor tyrosine kinase inhibitor for the treatment of triple negative breast cancer

被引：5
|
作者：
Pujuguet, Philippe [1 ]
Beirinckx, Filip [2 ]
Delachaume, Carole [1 ]
Huck, Jacques [1 ]
Van der Aar, Ellen [2 ]
Brys, Reginald [2 ]
Van Rompaey, Luc [2 ]
Wigerinck, Piet [2 ]
Saniere, Laurent [1 ]
机构：
[1] Galapagos, Romainville, France
[2] Galapagos, Mechelen, Belgium
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1753
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1753
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines In Vitro and In Vivo
    Colapietro, Alessandro
    Gravina, Giovanni Luca
    Petragnano, Francesco
    Fasciani, Irene
    Scicchitano, Bianca Maria
    Beirinckx, Filip
    Pujuguet, Philippe
    Saniere, Laurent
    Van der Aar, Ellen
    Musio, Daniela
    De Felice, Francesca
    Mattei, Vincenzo
    Martellucci, Stefano
    Maggio, Roberto
    Tombolin, Vincenzo
    Festuccia, Claudio
    Marampon, Francesco
    [J]. JOURNAL OF ONCOLOGY, 2020, 2020
  • [2] The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
    Gravina, Giovanni Luca
    Mancini, Andrea
    Colapietro, Alessandro
    Delle Monache, Simona
    Sferra, Roberta
    Vitale, Flora
    Cristiano, Loredana
    Martellucci, Stefano
    Marampon, Francesco
    Mattei, Vincenzo
    Beirinckx, Filip
    Pujuguet, Philippe
    Saniere, Laurent
    Lorenzon, Giocondo
    van der Aar, Ellen
    Festuccia, Claudio
    [J]. CANCERS, 2019, 11 (03)
  • [3] Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
    Megiorni, Francesca
    Gravina, Giovanni Luca
    Camero, Simona
    Ceccarelli, Simona
    Del Fattore, Andrea
    Desiderio, Vincenzo
    Papaccio, Federica
    McDowell, Heather P.
    Shukla, Rajeev
    Pizzuti, Antonio
    Beirinckx, Filip
    Pujuguet, Philippe
    Saniere, Laurent
    Van der Aar, Ellen
    Maggio, Roberto
    De Felice, Francesca
    Marchese, Cinzia
    Dominici, Carlo
    Tombolini, Vincenzo
    Festuccia, Claudio
    Marampon, Francesco
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [4] Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
    Francesca Megiorni
    Giovanni Luca Gravina
    Simona Camero
    Simona Ceccarelli
    Andrea Del Fattore
    Vincenzo Desiderio
    Federica Papaccio
    Heather P. McDowell
    Rajeev Shukla
    Antonio Pizzuti
    Filip Beirinckx
    Philippe Pujuguet
    Laurent Saniere
    Ellen Van der Aar
    Roberto Maggio
    Francesca De Felice
    Cinzia Marchese
    Carlo Dominici
    Vincenzo Tombolini
    Claudio Festuccia
    Francesco Marampon
    [J]. Journal of Hematology & Oncology, 10
  • [5] Understanding the kinomic contributions to tyrosine kinase inhibitor resistance in triple negative breast cancer
    Lefebvre, Cory
    Litchfield, David
    Allan, Alison
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [6] Possibility of Ephrin Receptor A10 as a Drug Target in Triple Negative Breast Cancer
    Kanasaki, S.
    Nagano, K.
    Yamashita, T.
    Maeda, Y.
    Inoue, M.
    Zhao, X.
    Abe, Y.
    Kamada, H.
    Tsutsumi, Y.
    Tsunoda, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S339 - S339
  • [7] Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer
    Jaradat, Sara K.
    Ayoub, Nehad M.
    Al Sharie, Ahmed H.
    Aldaod, Julia M.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [8] c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment
    Lopez-Mejia, Jose A.
    Tallabs-Utrilla, Luis F.
    Salazar-Sojo, Pablo
    Mantilla-Ollarves, Jessica C.
    Sanchez-Carballido, Manuel A.
    Rocha-Zavaleta, Leticia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [9] Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer
    Yao, Hang-Ping
    Suthe, Sreedhar Reddy
    Hudson, Rachel
    Wang, Ming-Hai
    [J]. DRUG DISCOVERY TODAY, 2020, 25 (07) : 1160 - 1173
  • [10] A role for receptor tyrosine kinase crosstalk in a Met-dependent model of triple-negative breast cancer
    Sung, Vanessa
    Knight, Jennifer F.
    Park, Morag
    [J]. MOLECULAR CANCER RESEARCH, 2013, 11
12345